AGF US Market Neutral Anti-Beta Fund
BTAL
7 hedge funds and large institutions have $2.52M invested in AGF US Market Neutral Anti-Beta Fund in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
1.7% more ownership
Funds ownership: 24.55% → 26.25% (+1.7%)
3% more capital invested
Capital invested by funds: $2.46M → $2.52M (+$67K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$546K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$212K |
| 3 |
Jane Street
New York
|
+$146K |
| 4 |
AWM
AllSquare Wealth Management
Albany,
New York
|
+$7.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$64.8K |
BTAL Hedge Fund Activity: Q3 2017 in Review
7 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in AGF US Market Neutral Anti-Beta Fund (BTAL) for Q3 2017, worth a combined $2.52M — up 2.7% from $2.46M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BTAL positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $546K. The largest seller was UBS Group, cutting an estimated $64.8K.
- 7 institutional investors held AGF US Market Neutral Anti-Beta Fund (BTAL) as of Q3 2017, up from 6 in Q2 2017.
- Funds reported $2.52M of AGF US Market Neutral Anti-Beta Fund stock for Q3 2017, up 2.7% quarter-over-quarter.
- 2 funds opened new AGF US Market Neutral Anti-Beta Fund positions in Q3 2017 and 0 closed out, a net change of +2 holders.
- The largest AGF US Market Neutral Anti-Beta Fund buyer in Q3 2017 was Virtu Financial, an estimated $546K added.
- The largest AGF US Market Neutral Anti-Beta Fund seller in Q3 2017 was UBS Group, an estimated $64.8K sold.
Based on aggregated 13F filings for Q3 2017.